A. Herranz-Alonso

发表

Use of the EFQM excellence model to improve hospital pharmacy performance.

C. Rodriguez-Gonzalez, C. Sarobe-González, M. Durán-García, 2020, Research in social & administrative pharmacy : RSAP.

Use of failure mode, effect and criticality analysis to improve safety in the medication administration process.

Ana Herranz-Alonso, Carmen Guadalupe Rodriguez-Gonzalez, Maria Luisa Martin-Barbero, 2015, Journal of evaluation in clinical practice.

Robotic dispensing improves patient safety, inventory management, and staff satisfaction in an outpatient hospital pharmacy

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2018, Journal of evaluation in clinical practice.

Development and Evaluation of a Clinical Decision Support System to Improve Medication Safety

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2019, Applied Clinical Informatics.

Guiding pharmacist clinical interviews: a safety tool to support the education of patients treated with oral antineoplastic agents

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2016, Expert opinion on drug safety.

Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2020, JMIR mHealth and uHealth.

Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis (Preprint)

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2019 .

Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety

A. Herranz-Alonso, M. Sanjurjo-Sáez, M. Herrera-Gutiérrez, 2020, Drugs in R&D.

Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety

C. Rodriguez-Gonzalez, A. Herranz-Alonso, V. Escudero-Vilaplana, 2020, Health Informatics J..

Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities

A. Herranz-Alonso, V. Escudero-Vilaplana, R. Collado-Borrell, 2018, Expert opinion on drug safety.

Concomitant use of sorafenib with ombitasvir/paritaprevir/ritonavir and dasabuvir: Effectiveness and safety in clinical practice

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2018, Journal of clinical pharmacy and therapeutics.

Effectiveness of a pilot intervention to reduce abciximab-related bleeding in patients with acute coronary syndromes

F. Fernández‐Avilés, H. Bueno, A. Herranz-Alonso, 2014, International Journal of Clinical Pharmacy.

Mobile Health Apps Providing Information on Drugs for Adult Emergency Care: Systematic Search on App Stores and Content Analysis

A. Herranz-Alonso, M. Sanjurjo, Beatriz Somoza-Fernández, 2021, JMIR mHealth and uHealth.

Mobile Health Apps Related to Emergency Drugs: Systematic Search on App Stores and Content Analysis (Preprint)

A. Herranz-Alonso, M. Sanjurjo-Sáez, Beatriz Somoza-Fernández, 2021 .

Optimisation of antithrombotic therapy in patients with acute coronary syndrome to reduce bleeding episodes

F. Fernández‐Avilés, H. Bueno, C. Rodriguez-Gonzalez, 2016, International journal of clinical practice.

Level of concordance between two risk-assessment models for predicting venous thromboembolism in medical patients at admission

A. Herranz-Alonso, M. Sanjurjo-Sáez, E. Duran-Garcia, 2015, European journal of hospital pharmacy. Science and practice.

Efficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice.

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2013, Clinical and experimental rheumatology.

Adequacy of Thromboembolic Prophylaxis Prescribed in an Emergency Department

A. Herranz-Alonso, M. Sanjurjo-Sáez, E. Duran-Garcia, 2013 .

Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey

A. Herranz-Alonso, V. Escudero-Vilaplana, R. Romero-Jimenez, 2022, Journal of medical Internet research.

Implementation of an enhanced recovery after surgery program including a patient school: Impact on quality of life results.

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2022, Injury.

Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co‐administration

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2016, Journal of clinical pharmacy and therapeutics.

A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2022, Frontiers in Public Health.

A comparative study of contamination in three closed systems for the preparation of hazardous drugs through simulations with fluorescein.

A. Herranz-Alonso, M. Sanjurjo-Sáez, I. Iglesias-Peinado, 2018, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan

A. Herranz-Alonso, M. Sanjurjo-Sáez, A. Gimenez-Manzorro, 2018, Revista brasileira de anestesiologia.

Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2018, The Annals of pharmacotherapy.

Switching to a rilpivirine/emtricitabine/tenofovir single‐tablet regimen in RNA‐suppressed patients infected with human immunodeficiency virus 1: Effectiveness, safety and costs at 96 weeks

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2017, International journal of clinical practice.

Smartphone applications for cancer patients; what we know about them?

Sara Ibáñez-García, Ana Herranz-Alonso, María Sanjurjo-Sáez, 2016, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2016, International Journal of Clinical Pharmacy.

PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort.

C. Rodriguez-Gonzalez, M. Durán-García, A. Herranz-Alonso, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Oral antineoplastic agent interactions with medicinal plants and food: an issue to take into account

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2016, Journal of Cancer Research and Clinical Oncology.

Thalidomide as treatment of refractory thoracic Rosai‐Dorfman disease

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2021, Journal of clinical pharmacy and therapeutics.

Effectiveness, Safety, and Costs of Dolutegravir/Abacavir/Lamivudine Single-Tablet Regimen in a Real-Life Cohort of HIV-1 Adult Infected Patients

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2020, The Annals of pharmacotherapy.

Pharmacotherapy follow‐up of key points in the safety of oral antineoplastic agents

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2017, European journal of cancer care.

The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search

A. Herranz-Alonso, V. Escudero-Vilaplana, M. Sanjurjo, 2021, Journal of medical Internet research.

Clinical evaluation of pulmonary hypertension using patient-reported outcomes: a cross-sectional study

A. Herranz-Alonso, M. Sanjurjo-Sáez, T. Mombiela, 2021, BMC Pulmonary Medicine.

Influence on effectiveness of early treatment with anti-TNF therapy in rheumatoid arthritis.

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2012, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2021, Frontiers in Oncology.

Prevalence of medication administration errors in two medical units with automated prescription and dispensing

Ana Herranz-Alonso, Carmen Guadalupe Rodriguez-Gonzalez, Maria Luisa Martin-Barbero, 2012, J. Am. Medical Informatics Assoc..

Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2018, Journal of medical Internet research.

Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2020, Expert opinion on drug safety.

Features and Functionalities of Smartphone Apps Related to COVID-19: Systematic Search in App Stores and Content Analysis

Ana Herranz-Alonso, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, 2020, Journal of medical Internet research.

Patient-reported outcomes and mobile applications. A review of their impact on patients' health outcomes.

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2022, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Patient-reported outcomes and mobile applications . A review of their impact on patients ’ health outcomes Patient-reported outcomes

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2022 .

Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients With Cancer on Their Health Outcomes: Quasi-Experimental Study

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2020, JMIR mHealth and uHealth.

Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2023, European journal of hospital pharmacy : science and practice.

Adding value through pharmacy validation: a safety and cost perspective.

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2016, Journal of evaluation in clinical practice.

Design of the functional requirements of a smartphone app for patients receiving oral antineoplastic agents: The e-OncoSalud® app

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Novel mobile application for direct communication between pharmacists and patients treated with oral antineoplastic agents.

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2020, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Clinical and Economic Impact of a Multisciplinary Intervention to Reduce Bleeding Risk in Patients With Acute Coronary Syndrome.

H. Bueno, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2017, Revista espanola de cardiologia.

Topical Administration of Amphotericin B as an Effective Adjuvant Treatment for a Deep Fungal Infection of Diabetic Foot Injury.

C. Rodriguez-Gonzalez, A. Herranz-Alonso, M. Sanjurjo-Sáez, 2020, American journal of therapeutics.

DD-014 Staff satisfaction after the implementation of a robotic dispensing system in an outpatient pharmacy

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2016 .

Oral antineoplastic agents: assessment of safety and dose adjustments in clinical practice

A. Herranz-Alonso, V. Escudero-Vilaplana, A. Gimenez-Manzorro, 2019, Expert opinion on drug safety.

[TRANSLATED ARTICLE] Achieving excellence in the pharmaceutical care of the surgical patient.

A. Herranz-Alonso, M. Sanjurjo-Sáez, M. L. Martin-Barbero, 2023, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Achieving excellence in the pharmaceutical care of the surgical patient.

A. Herranz-Alonso, M. Sanjurjo-Sáez, M. L. Martin-Barbero, 2023, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare

A. Herranz-Alonso, V. Escudero-Vilaplana, R. Romero-Jimenez, 2022, Frontiers in Immunology.

Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2021, JMIR mHealth and uHealth.

Smartphone applications for cancer patients; what we know about them?

A. Herranz-Alonso, M. Sanjurjo-Sáez, V. Escudero-Vilaplana, 2016, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.